Top IT Companies in Washington, DC (582)

Strong Revenue Growth: Financial statements indicate total revenue rose from $499.7M in 2024 to $737.5M in 2025, with clearing‑fee revenue increasing materially over the same period. Operating data into 2026 shows elevated activity levels, consistent with continued top‑line momentum.

Profitability: Net income increased from $70.2M in 2024 to $190.7M in 2025, and operating income shifted from losses in prior years to a positive result. This reflects improved earnings alongside higher clearing volumes.

Resilient & Sustainable Growth: Contracts cleared reached record levels in 2025 and continued to expand into 2026, while the securities‑lending program also grew in value and transactions. Multi‑year trends from 2020 to 2025 show options activity more than doubling, indicating durable expansion.

Strong Revenue Growth: Revenue is rising year over year, with H1 2026 up 11% and Q1/Q2 growing 14% and 8% respectively, supported by higher commercial-aircraft deliveries. This momentum reflects increased production throughput and broader top-line recovery.

Healthy Cash Flow: Cash generation is improving, as H1 2026 operating cash flow turned positive and free cash flow improved, including a positive result in Q2. This shift indicates better working-capital dynamics alongside rising delivery volume.

Strong Market Position & Advantage: Backlog is at a record level of roughly $715 billion, including more than 6,200 commercial aircraft. This depth of contracted demand provides multi‑year visibility for production and revenue.

Strong Revenue Growth: Inc. 5000 recognitions cite 82% and 72% three-year growth, and investor disclosures note meaningful 2025 revenue scale, indicating sustained multi-year expansion. While precise YoY rates aren’t public, repeated list appearances and disclosed scale point to continued momentum.

Investor Backing & Capital Strength: Nordic Capital became the majority owner in 2025 to support the next phase of growth, expansion, and platform investment. Additional financing and stated plans for strategic acquisitions further reinforce access to growth capital.

Market Expansion: Customer and data footprint expanded to 170M+ patient records across 200+ provider/payer organizations, with more than 2.25M value-based lives added in 2024. Management and media describe ambitions for further expansion via M&A and potential moves beyond the U.S.

Strong Revenue Growth: Sales increased 10% in 2025 and 9% in H1 2026, with leadership upgrading 2026 guidance to 8–10% sales growth. Growth was reported across all major sectors.

Profitability: Underlying EBIT rose 12% in 2025 and 11% in H1 2026, alongside an improved return on sales. This points to stronger margins in addition to top-line expansion.

Resilient & Sustainable Growth: A record order backlog of roughly £83.6–84.0 billion and multi‑year contracts provide substantial future revenue visibility. The 2026 outlook also signals continued expansion.

Strong Revenue Growth: Recent results show revenue rising in the mid-30% year over year, with acceleration from Q1 to Q2 2026 and raised full-year 2026 guidance. Contracted demand indicators such as Current RPO also increased in the mid-30% range, reinforcing momentum.

Diversified Customer Base: Evidence points to a broad customer mix, from hundreds of thousands of paying customers to thousands of large enterprises, including a significant share of the Fortune 500. Growth in $100K+ and $1M+ spend cohorts underscores continued upmarket penetration.

Healthy Cash Flow: Observations include positive and increasing free cash flow alongside strong operating cash generation in recent periods. These trends suggest the business is funding growth while improving cash efficiency.

Strong Revenue Growth: Revenue is considered to be expanding rapidly, with recent quarters showing accelerated year-over-year gains in both total and subscription revenue. Multi-year growth at a high double-digit pace is also evident in the latest annual results.

Resilient & Sustainable Growth: Contracted revenue indicators appear robust, with total RPO at $29.0B and current RPO at $13.2B in Q2 2026. Management also raised its full-year 2026 subscription outlook, signaling confidence in continued expansion.

Innovation-Driven Growth: Newer AI offerings are gaining commercial traction, with ServiceNow AI surpassing $1 billion in annual contract value and agentic deployments scaling quickly. Large-deal activity and the count of very large customers also increased, indicating product-led expansion.

Profitability: Net income turned from -$27.9M in FY2025 to +$37.9M in FY2026, and adjusted EBITDA rose from $67.0M to $107.3M with margin expansion. Profitability continued into FY2027 with strong quarterly EBITDA performance.

Cost & Operational Efficiency: Operating discipline, restructuring, and reduced expenses are credited with materially improving margins and earnings despite muted top-line trends. The business has shifted from loss-making expansion to efficiency and margin expansion.

Future-Ready Strategy: Product investments and positioning around AI/agentic marketing (e.g., Scout, Corvo AI) and targeted acquisitions (e.g., Hearsay) indicate a pivot toward AI-driven search visibility and regulated-industry use cases. This suggests preparation for evolving demand rather than reliance solely on legacy listings revenue.

Profitability: Investment performance is described as exceptional over multiple years, with LCH citing record cumulative net gains and annual investor profits including a record ~$16B in 2022 and further multibillion-dollar gains in 2023–2024. This track record positions the firm at or near the top of cumulative profitability rankings.

Strong Revenue Growth: Trading revenue at the affiliated market maker rose sharply, reaching a record ~$12.2B in 2025 and accelerating further with multi‑billion‑dollar quarters in 2026. This momentum indicates expanding top‑line scale alongside broader business activity.

Market Expansion: The geographic footprint is widening with Dubai slated as the 18th city, a growing London hub, and new or expanded sites such as New York, Miami, and Amsterdam. International hiring and build‑outs across Asia and Europe further reinforce expansion into additional markets.

Strong Revenue Growth: Revenue is consistently climbing across 2025 and into 2026, with management increasing full‑year guidance after stronger‑than‑expected quarters. Momentum is led by U.S. Financial Services and Emerging Verticals, with multiple quarters of high single‑ to double‑digit organic growth noted.

Profitability: Net income and adjusted earnings expanded alongside revenue, and adjusted EBITDA also increased. This points to improving operating leverage as growth scales across key segments.

Diversified Revenue Streams: Multiple business lines—including credit, fraud/identity, marketing, and international operations—are contributing to results. Expansion such as taking majority ownership in the Mexico bureau and broad-based U.S. segment strength reduce reliance on any single product or geography.

Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.

Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.

Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.

Strong Revenue Growth: Revenue appears to be increasing over time, with evidence of substantial growth in 2022 and continued year-over-year expansion into early 2023, even as the pace moderates. Feedback suggests the business is still scaling toward a larger revenue base while transitioning to a mature growth profile.

Profitability: Independent credit commentary highlights improved profitability and a deliberate shift toward a profit-focused operating model. Feedback suggests efficiency gains and margin improvement are becoming central to the company’s stability and growth trajectory.

Innovation-Driven Growth: Ongoing AI platform investment, rising adoption of AI capabilities, and product expansion including acquisitions are cited as current growth engines. Feedback suggests these initiatives are supporting continued operational and market expansion.

Strong Revenue Growth: Revenue and annual recurring revenue are increasing at a robust pace, with recent quarters showing re-acceleration and a raised full‑year outlook. This momentum is supported by record net new recurring business and continued customer and module expansion.

Healthy Cash Flow: Operating and free cash flow are at record levels for recent periods, underscoring strong cash generation alongside growth. Liquidity is reinforced by scaling cash from operations as the platform expands.

Profitability: GAAP profitability has improved from prior losses to positive territory, with operating leverage trending upward. This shift indicates improving economics as scale increases.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.